Avantor vs Bio-Rad Laboratories
Avantor (AVTR), health care, and Bio-Rad Laboratories (BIO), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Avantor is worth $10.3B on the stock market and Bio-Rad Laboratories $9.6B: Avantor is valued at 7% more. Avantor trades at 30.4 times earnings and Bio-Rad Laboratories at 9.5; operating margins in their latest fiscal years were -3.76% and 1.83%. Over the past year Avantor's share price has moved +37.5% and Bio-Rad Laboratories's +17.1%.
Key facts
- Avantor market value
- $10.3B
- Bio-Rad Laboratories market value
- $9.6B
- Avantor P/E
- 30.4
- Bio-Rad Laboratories P/E
- 9.5
- Avantor revenue
- $6.6BFY to 2025-12-31
- Bio-Rad Laboratories revenue
- $2.6BFY to 2025-12-31
- Superinvestors holding both
- 1
Market values as of .
| Measure | Avantor | Bio-Rad Laboratories |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $10.3Bhigher | $9.6Blower |
| Revenue | $6.6Bhigher | $2.6Blower |
| Earnings | -$530.2Mlower | $759.9Mhigher |
| Employees | 13,500higher | 7,450lower |
| Total assets | $11.8Bhigher | $10.6Blower |
| Valuation | ||
| P/E | 30.4higher | 9.5lower |
| P/S | 1.6lower | 3.7higher |
| P/B | 1.8higher | 1.3lower |
| Dividend yield | 0.00% | 0.00% |
| Profitability | ||
| Operating margin | -3.76%lower | 1.83%higher |
| Balance sheet | ||
| Net assets | $5.6Blower | $7.5Bhigher |
| Total liabilities | $6.2Bhigher | $3.1Blower |
| Total debt | $3.9Bhigher | $1.2Blower |
| Cash on hand | $365.4Mlower | $529.8Mhigher |
| Price change | ||
| Today | -0.91%lower | -0.57%higher |
| 1 year | +37.5%higher | +17.1%lower |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (1)
- Steven Romick1.1% / 1.2%
Avantor only (8)
- Arnaud Ajdler19.1%
- Edgar Wachenheim4.6%
- Mason Hawkins2.4%
- David Greenspan1.6%
- Dodge & Cox team1.0%
- Stephen Yacktman0.9%
- Chuck Royce (founder)0.5%
- Diamond Hill team0.2%
Bio-Rad Laboratories only (2)
- John Rogers3.1%
- Matthew McLennan1.5%
Percentages are each holding's share of that investor's reported portfolio (under "Both": Avantor / Bio-Rad Laboratories). Who owns AVTR · Who owns BIO
More on Avantor
Further comparisons
Avantor against its closest peers
Bio-Rad Laboratories against its closest peers
Learn
Questions and answers
Which is bigger, Avantor or Bio-Rad Laboratories?
By market value, Avantor is the larger: $10.3B against $9.6B for Bio-Rad Laboratories. By revenue in its latest fiscal year, Avantor is the larger: $6.6B against $2.6B for Bio-Rad Laboratories.
Which has the higher P/E ratio?
Avantor: 30.4, against 9.5 for Bio-Rad Laboratories. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher operating margin?
Bio-Rad Laboratories: 1.83%, against -3.76% for Avantor. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which has the higher dividend yield?
Neither: both stand at 0.00%. Dividend yield is the last twelve months' dividends as a share of today's share price.
Which has more debt?
Avantor: $3.9B, against $1.2B for Bio-Rad Laboratories. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both Avantor and Bio-Rad Laboratories?
In their latest 13F filings, Steven Romick holds both.
Cite this page
Funkfolio, “Avantor vs Bio-Rad Laboratories”, data as of 17 November 2026. https://funkfolio.com/compare/avtr-vs-bio
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.